2018
DOI: 10.1111/cas.13653
|View full text |Cite
|
Sign up to set email alerts
|

CXCR4‐mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA‐613

Abstract: Osteosarcoma is the most common primary bone malignancy. Recently, studies showed chemokine receptor 4 (CXCR4) played a critical role in osteosarcoma. However, the regulation of CXCR4 is not fully understood. microRNAs are short, non‐coding RNAs that play an important roles in post‐transcriptional regulation of gene expression in a variety of diseases including osteosarcoma. miR‐613 is a newly discovered miRNA and has been reported to function as a tumor suppressor in many cancers. In this study, we confirmed … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
31
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 46 publications
(33 citation statements)
references
References 36 publications
2
31
0
Order By: Relevance
“… 28 – 30 Zhu et al reported that MiR-613 directly suppressed CXCR4 expression and then decreased the proliferation, migration, and induced apoptosis of osteosarcoma cells. 31 Another report found that lncRNA CYTOR promoted the invasion and migration of nasopharyngeal carcinoma cells by targeting the miR-613/ANXA2 axis. 32 Of note, the target gene of miR-613 in lung cancer was recently reported.…”
Section: Discussionmentioning
confidence: 99%
“… 28 – 30 Zhu et al reported that MiR-613 directly suppressed CXCR4 expression and then decreased the proliferation, migration, and induced apoptosis of osteosarcoma cells. 31 Another report found that lncRNA CYTOR promoted the invasion and migration of nasopharyngeal carcinoma cells by targeting the miR-613/ANXA2 axis. 32 Of note, the target gene of miR-613 in lung cancer was recently reported.…”
Section: Discussionmentioning
confidence: 99%
“…Osteosarcoma is a malignant primary bone tumor, which occurs mainly in adolescents and young adults . In patients with metastatic osteosarcoma or with distant disease relapse after localized disease treatment, the long‐term overall survival (OS) rate is <20% .…”
Section: Introductionmentioning
confidence: 99%
“…Osteosarcoma is a malignant primary bone tumor, which occurs mainly in adolescents and young adults . In patients with metastatic osteosarcoma or with distant disease relapse after localized disease treatment, the long‐term overall survival (OS) rate is <20% . Currently, treatment modalities for osteosarcoma include surgery, chemotherapy, radiotherapy, and immunotherapy; among these, radical resection and implant selection are very crucial .…”
Section: Introductionmentioning
confidence: 99%
“…9,10 For instance, miR-506-3p functions as a tumour suppressor by suppressing the proliferation and metastasis of OS cells via targeting RAB3D. 12 While, our previous study reports that miR-92a is overexpressed in OS tissues and facilitates tumour growth of OS via suppressing phosphatase and tensin homologue (PTEN) and AKT signalling pathway. 12 While, our previous study reports that miR-92a is overexpressed in OS tissues and facilitates tumour growth of OS via suppressing phosphatase and tensin homologue (PTEN) and AKT signalling pathway.…”
mentioning
confidence: 99%
“…11 MiR-613 inhibits OS cell proliferation and migration, and induces apoptosis by targeting chemokine receptor 4 (CXCR4). 12 While, our previous study reports that miR-92a is overexpressed in OS tissues and facilitates tumour growth of OS via suppressing phosphatase and tensin homologue (PTEN) and AKT signalling pathway. 13 Recently, A new tumour-suppressive miR-876-5p has been found to play important roles in a variety of tumours including lung cancer, 14 oesophageal squamous cell carcinoma (ESCC), 15 hepatocellular carcinoma (HCC) 16,17 and head and neck squamous cell carcinoma (HNSCC).…”
mentioning
confidence: 99%